From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
“Having a solution that brings together all of our channel and specialty pharmacy data and feeds our data warehouse is essential for our future success.”
Director | Specialty Data Management & Analytics
With a channel strategy in place, manufacturers can effectively report on weekly builds and burns in downstream inventory, accurately assess their gross to net accruals, and proactively adjust reserves so they can more reliably land on the budget numbers.
IntegriChain is able to leverage manufacturers’ enriched 867 and EXF data sets to perform a downstream inventory analysis. By using this data set accompanied by Symphony Health’s non-projected TRx data, manufacturers are positioned to have an accurate inventory roll-forward and better able to answer questions such as:
IntegriChain’s Channel & Patient Data Consulting specializes in the following key areas:
Speak with a Consultant
This case study focuses on a pharmaceutical manufacturer who, despite using an established third-party logistics (3PL) provider, was struggling with both inconsistent channel data as well as the lack of visibility into downstream inventory.
Download
This case study highlights how IntegriChain delivered payer data solutions to help the manufacturer identify and resolve obstacles to patient access. As their market access needs evolved to contracting, channel, and gross-to-net, IntegriChain had the optimal solution.
Read
